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Abstract
Background
The epidemiology, clinical presentation and management of melioidosis vary around
the world. It is essential to define the disease’s local features to optimise its manage-
ment.
Principal findings
Between 1998 and 2016 there were 197 cases of culture confirmed melioidosis in Far
North Queensland; 154 (78%) presented in the December-April wet season. 145 (74%)
patients were bacteraemic, 58 (29%) were admitted to the Intensive Care Unit and 27
(14%) died; nine (33%) of these deaths occurred within 48 hours of presentation. Pneu-
monia was the most frequent clinical finding, present in 101 (61%) of the 166 with avail-
able imaging. A recognised risk factor for melioidosis (diabetes, hazardous alcohol use,
chronic renal disease, chronic lung disease, immunosuppression or malignancy) was
present in 148 (91%) of 162 patients with complete comorbidity data. Despite represent-
ing only 9% of the region’s population, Aboriginal and Torres Strait Island (ATSI) people
comprised 59% of the cases. ATSI patients were younger than non-ATSI patients
(median (interquartile range): 46 (38–56) years versus 59 (43–69) years (p<0.001) and
had a higher case-fatality rate (22/117 (19%) versus 5/80 (6.3%) (p = 0.01)). In the 155
patients surviving the initial intensive intravenous phase of treatment, eleven (7.1%) had
disease recurrence, despite the fact that nine (82%) of these patients had received pro-
longed intravenous therapy. Recurrence was usually due to inadequate source control or
poor adherence to oral eradication therapy. The case fatality rate declined from 12/44
(27%) in the first five years of the study to 7/76 (9%) in the last five (p = 0.009), reflecting
national improvements in sepsis management.
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Conclusions
Melioidosis in Far North Queensland is a seasonal, opportunistic infection of patients with
specific comorbidities. The ATSI population bear the greatest burden of disease. Although
the case-fatality rate is declining, deaths frequently occur early after hospitalisation, reinforc-
ing the importance of prompt, targeted therapy in high-risk patients.
Author summary
Burkholderia pseudomallei is endemic to the tropics and is responsible for the disease
melioidosis. Exposure rarely evolves to significant disease in the absence of specific
comorbidities. Conversely, in susceptible hosts, the disease can be rapidly fatal if unrecog-
nised. Patients require an extended course of intravenous and oral antibiotic therapy to
treat the disease and to prevent its recurrence. This retrospective, case series describes the
epidemiology, presentation and outcomes of 197 cases of melioidosis in Far North
Queensland (FNQ), Australia. The study confirms that melioidosis is predominantly a
seasonal, opportunistic infection occurring among patients with specific comorbidities
that include diabetes mellitus, hazardous alcohol use, chronic kidney disease, chronic
lung disease, malignancy and immunosuppressive therapy. Melioidosis is more common
in the local Aboriginal and Torres Strait Islander (ATSI) population, which has a higher
prevalence of these comorbidities. Although overall case-fatality rates are declining, they
are higher in the ATSI population, reflecting ongoing socioeconomic disadvantage. Dis-
ease recurrence is more likely in patients with inadequate source control and suboptimal
adherence, factors that are not necessarily mitigated by extending the duration of intrave-
nous therapy.
Introduction
Burkholderia pseudomallei, an environmental bacterium endemic to the tropics, is responsible
for the disease melioidosis [1]. Serological studies suggest that B. pseudomallei infection is usu-
ally asymptomatic; however, it may also cause a rapidly fatal illness, particularly in those with
co-morbidities [2, 3]. Pneumonia is the commonest presentation, however almost any organ
can be involved with the liver, spleen, kidney and prostate regularly affected [1, 4]. Patients
with melioidosis are frequently bacteraemic and often present in septic shock, but solitary skin
lesions without systemic manifestations are a common presentation in children and adults
without risk factors [1].
The epidemiology and clinical manifestations of the disease vary in different geographical
locations [1, 5]. This may be explained by differences in the local prevalence of comorbidities
and variable access to sophisticated diagnostic facilities. The route of infection (percutaneous,
inhalation or ingestion) is increasingly thought to also have a major influence on presentation
[6]. These geographical differences in the clinical features of melioidosis have implications for
empirical management of sepsis. There are also ramifications for the disease’s relatively com-
plex treatment regimen: a minimum of 10–14 days of intravenous antibiotics (intensive phase)
followed by at least 3 months of oral antibiotics (eradication phase) is usually recommended,
but in cases of extensive or complicated disease, an even longer duration of antibiotic therapy
is advised [7].
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However, even with adherence to these treatment recommendations, disease relapse is still
seen. In one series from the Northern Territory of Australia, 4.3% of patients surviving the inten-
sive phase of therapy had molecularly confirmed relapse [8]. In a Thai series, the relapse rate was
9.3% [9]. This relatively high rate of relapse—and the recognition that there is frequently poor
adherence to the long course of oral therapy—has led to a suggestion that patients may benefit
from an extended phase of intravenous therapy. A longer phase of intravenous therapy was asso-
ciated with very low relapse rates in a recent series from Darwin [10]. However, while there are
plausible arguments for this strategy, it has not been evaluated in other locations.
This retrospective case series was performed to define the epidemiology, presentation, clini-
cal course and response to treatment of melioidosis in Far North Queensland in Australia. In
addition, by correlating local relapse rates with the duration of intensive intravenous therapy,
it aimed to determine if the apparent efficacy of the Darwin treatment guideline could be dem-
onstrated at an independent site.
Methods
Cairns Hospital is a 531 bed, tertiary referral hospital located in the tropical Far North of the
state of Queensland, Australia. It serves a population of approximately 280,000 people, 9% of
whom identify as Aboriginal or Torres Strait Islanders (ATSI) (Fig 1) [11]. Patients were eligi-
ble for inclusion in the study if they had a positive laboratory culture for B. pseudomallei in
Cairns Hospital laboratory, the sole microbiology provider for FNQ health services, between
January 1, 1998 and July 31, 2016
The hospital medical record of each case was reviewed to determine the patients’ demo-
graphics, their clinical presentation, their comorbidities and their disease course (Fig 2). Haz-
ardous alcohol use was said to be present if it had been documented in the medical record in
the 12 months prior to presentation. Chronic lung disease was said to be present if a patient
was receiving any ongoing treatment for a chronic lung condition. Chronic kidney disease was
said to be present if there had been a serum creatinine 150 μmol/L documented before the
presentation. Immunosuppression was said to be present if the patent was using immunosup-
pressive agents, including corticosteroids, chemotherapy, or immunomodulatory therapies.
The presence of an active malignancy was also recorded. Admission to the Intensive Care Unit
Fig 1. A. Australia climate map [12]. B. Far North Queensland: annual disease incidence by region (expressed per
100,000 population) and Queensland Health Service Districts [41].
doi:10.1371/journal.pntd.0005411.g001
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(ICU), the use of mechanical ventilation and renal replacement therapy (RRT) was docu-
mented; septic shock was defined as a requirement for vasopressors. The duration of the inten-
sive and proposed eradication phase of treatment was also documented; this was compared to
published recommendations from Darwin [10]. Adherence to eradication therapy was deter-
mined from the medical record and outpatient letters. The state-wide laboratory database was
examined to identify culture confirmed treatment failure.
Death attributable to melioidosis within 90 days of diagnosis was documented. Disease
recurrence was defined as clinical deterioration in association with a positive culture for B.
pseudomallei. This was further defined as recrudescence if it occurred after completion of the
intensive phase of intravenous therapy, during the time that oral eradication therapy was rec-
ommended, whether this therapy was being taken or not. In the absence of molecular typing,
disease recurrence was defined as relapse–rather than reinfection—if it occurred within two
years of the recommended completion date of oral therapy, whether this therapy had been
taken or not [13]. Australian Bureau of Statistics population data were used to determine dis-
ease incidence [11]; while Bureau of Meteorology data were used to explore the link with rain-
fall [14].
Statistical analysis
Data were de-identified, entered into an electronic database and analysed with statistical soft-
ware (Stata 10). Groups were analysed using the Kruskal-Wallis and chi-squared tests.
Ethics review
The study received ethical approval from the Far North Queensland Human Research Ethics
Committee (HREC/15/QCH/46–977), as per this approval this retrospective study with anon-
ymized patient data did not obtain individual patient consent.
Fig 2. Data collection and its completeness.
doi:10.1371/journal.pntd.0005411.g002
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Results
Over the course of the study period the annual incidence was higher in the Torres Strait (33.1/
100,000 population) and on Cape York (12.1/100,000 population) than in Cairns and sur-
rounds (1.7/100,000 population) (Fig 1). Although the number of cases varied from four to 26
per year, in every year they clustered around the region’s December to April wet season (Figs 3
& 4).
During the study period, 197 individuals (median age 50 years; range 2 days to 92 years)
had B. pseudomallei isolated (Fig 4); 147 (75%) were male and 50 (25%) were female; 117
(59%) identified as ATSI, 80 (41%) did not identify as ATSI. The mean annual incidence in the
ATSI population over the study period was 14.0/100,000 population versus 1.9/100,000 popu-
lation in the non-ATSI population. ATSI patients were younger (median 46 years (interquar-
tile range (IQR): 38–56) than non-ATSI patients (median (IQR): 59, 43–69 years) (p< 0.001).
Of the 162 patients with complete data, only 14 (8.6%) had no apparent risk factor for the
disease. In patients with sufficient data to determine if the risk factor was present, 102/182
(56%) had diabetes mellitus, 86/166 (52%) had hazardous alcohol use and 28/180 (16%) had
chronic kidney disease. Chronic lung disease was present in 26/169 (15%), while immunosup-
pression or malignancy was present in 27/168 (16%) (Table 1). Of the 162 patients with com-
plete data, 85 (52%) had more than one risk factor. The ATSI population were more likely to
have diabetes and chronic kidney disease, while lung disease was more common in the non-
ATSI population. The ATSI population were more likely to have multiple risk factors for the
disease while the non-ATSI population was more likely to have no documented risk factor
(Table 2).
Of the 197 patients, 145 (74%) were bacteraemic. Septic shock was present on admission or
early in the hospitalisation in 58 (34%) of the 175 patients in whom this could be determined
Fig 3. Relationship between the monthly rainfall and the timing of clinical presentation.
doi:10.1371/journal.pntd.0005411.g003
Melioidosis in Far North Queensland
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005411 March 6, 2017 5 / 15
(Table 3). Pneumonia was the most common presentation, occurring in 101 (61%) of the 166
patients with chest imaging (Table 4). An abscess was present in 89 (53%) of the 166 patients
who had either complete imaging or an operation report documenting a culture positive aspi-
rate; 15 (9%) had abscesses in multiple organs.
The disease was directly responsible for 27 (15%) deaths during the study period although
the case fatality rate declined over time (test for trend p = 0.009): in the first 5 years of the
study period 12/44 (27%) died, compared with 7/76 (9%) in the last 5 years. There was no sig-
nificant increase in the rates of ICU admission and the use of vasopressors, RRT or mechanical
ventilation over the study period to explain this improvement (Table 3). Nine (33%) of the 27
deaths, occurred within the first 48 hours of the patient’s presentation and 13 (48%) occurred
within the first seven days. There were 22 (19%) deaths among the 117 ATSI patients versus
five (6.3%) in the 80 non-ATSI patients (p = 0.01). While there was a trend towards the ATSI
population requiring more critical care support including admission to ICU (38% versus
27% in non-ATSI patients, p = 0.11), mechanical ventilation (32% versus 21% in non-ATSI
patients, p = 0.11) and RRT (13% versus 7%, p = 0.18) this did not achieve statistical signifi-
cance. All three patients under ten years of age died. In adults, the case fatality rate increased
with increasing age (p = 0.03) (Fig 5). The only comorbidity associated with death in univariate
analysis was chronic kidney disease (Table 1).
In the 155 patients with complete data who survived the intensive intravenous therapy
phase, there were eleven (7.1%) with a microbiologically confirmed recrudescence or relapse
(Table 5). Of the 155 patients, 107 (69%) received intravenous therapy for a period that was
greater than or equal to that recommended in the Darwin guidelines [10]. Nine (8.4%) of these
107 patients had either recrudescence (seven) or relapse (two); two of these patients died,
although in one of these cases, outpatient parenteral therapy was interrupted for 72 hours dur-
ing a category 5 cyclone. Two (4.2%) of the 48 patients with an intensive treatment duration of
Fig 4. Year of presentation and case-fatality rate.
doi:10.1371/journal.pntd.0005411.g004
Melioidosis in Far North Queensland
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005411 March 6, 2017 6 / 15
less than that recommended in the Darwin guidelines had recurrence. There was one recrudes-
cence and one relapse; both patients survived.
In the eleven patients with a microbiologically confirmed recrudescence or relapse, this
could be explained by suboptimal source control in four patients and poor adherence to pre-
scribed eradication therapy in another five. Recrudescence also occurred in one patient with
an ulcerated skin lesion in whom surgical debridement was considered, but not performed; he
also subsequently had poor adherence to eradication therapy (Table 5).
There were a further two patients who had a recurrence of melioidosis several years after
their initial eradication therapy. Both patients had an intensive phase of treatment less than
that recommended in the Darwin guidelines and neither was adherent to eradication therapy.
Table 1. Disease risk factors and their relationship with mortality.
Risk Factor Number N Deaths N (%) Survived N (%) P a
Male Yes 147 (75) 19 (13) 128 (87) 0.59
No 50 (25) 8 (16) 42 (84)
ATSI Yes 117 (59) 22 (19) 95 (81) 0.01
No 80 (41) 5 (6) 75 (94)
Diabetes mellitus Yes 103 (56) 12 (12) 90 (88) 0.71
No 80 (44) 8 (10) 72 (90)
Hazardous alcohol intake Yes 86 (51) 9 (10) 77 (90) 0.92
No 80 (49) 8 (10) 72 (90)
Chronic kidney disease Yes 28 (16) 7 (25) 21 (75) 0.004
No 152 (84) 11 (7) 141 (93)
Chronic lung disease Yes 26 (16) 3 (11) 23 (89) 0.60
No 143 (84) 12 (8) 131 (92)
Immunosuppression Yes 17 (10) 2 (12) 15 (88) 0.59
No 151 (90) 12(8) 139 (92)
Malignancy Yes 14 (8) 1 (7) 13 (93) 0.87
No 154 (92) 13 (8) 141 (92)
No risk factor Yes 14 (8) 2 (14) 12 (86) 0.43
No 148 (92) 12 (8) 136 (92)
Overall 197 27 (14) 170 (86) -
a For the association with death calculated using chi square.
ATSI: identifying as Aboriginal or Torres Strait Islanders.
doi:10.1371/journal.pntd.0005411.t001
Table 2. The presence of risk factors for disease, stratified by ATSI status.
Number a Remote
location b
Diabetes
mellitus
Hazardous alcohol
consumption
Chronic kidney
disease
Chronic lung
disease
Multiple risk
factors
No recognised
risk factor
ATSI 117 92/117 (79) 77/105 (73) 52/93 (56) 21/103 (20) 7/95 (7) 54/90 (60) 3/90 (3)
Non-
ATSI
80 22/80 (28) 25/77 (32) 34/73 (47) 7/77 (9) 19/74 (26) 31/72 (43) 11/72 (15)
P value c <0.001 <0.001 0.23 0.04 0.001 0.03 0.007
a Incomplete data for some risk of the factors.
b Outside of metropolitan centres.
c Determined using Chi-square.
ATSI: identifying as Aboriginal or Torres Strait Islander.
doi:10.1371/journal.pntd.0005411.t002
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In the absence of molecular typing, it was not possible to determine whether these two cases
represented relapse or reinfection, although reinfection is suspected based on the interval
durations of relapse and reinfection seen in other studies [8, 13]. One–with a recurrence four
years after his initial presentation–had poorly controlled diabetes, ongoing hazardous alcohol
use, end stage renal disease requiring haemodialysis and hepatocellular carcinoma; the other—
with disease recurrence five years after his initial presentation—had poorly controlled diabetes
(glycosylated haemoglobin persistently above 10%).
Discussion
Melioidosis in Far North Queensland is, very largely, a seasonal, opportunistic disease of
patients with specific co-morbidities. Patients are commonly bacteraemic and frequently
require ICU admission. Even with ICU support, the disease has a high attributable case-fatality
rate, although this is declining. ATSI patients bear the greatest burden of disease, develop the
disease at a younger age and have a higher case fatality rate, despite similar access to ICU sup-
port. The disease has a very similar epidemiology and clinical presentation to that in the
Northern Territory, but unlike the Territory patients, those in Queensland receiving extended
courses of intensive, intravenous antibiotic therapy still had relatively high rates of disease
recurrence. These recurrences were often explained by suboptimal source control and poor
adherence to the eradication phase of treatment.
Table 3. Disease severity, outcome and supportive care over the course of the study.
Variable 1998–2002 2003–2006 2007–2011 2012–2016 Total
Number (%) Number (%) Number (%) Number (%) Number (%)
Died 12/44 (27) 6/34 (18) 2/43 (5) 7/76 (9) 27/197 (14)
Bacteraemic 30/44 (68) 23/34 (68) 34/43 (79) 58/76 (76) 145/197 (74)
ICU admission 11/29 (38) 14/31 (45) 12/39 (31) 21/76 (28) 58/175 (33)
Septic shock 11/29 (38) 15/31 (48) 12/39 (31) 20/76 (26) 58/175 (33)
Mechanical ventilation 10/28 (36) 14/31 (45) 11/39 (28) 12/76 (16) 47/174 (27)
RRT 3/24 (13) 5/30 (17) 5/39 (13) 4/76 (5) 17/169 (10)
ICU: Intensive Care Unit; RRT: Renal replacement therapy.
doi:10.1371/journal.pntd.0005411.t003
Table 4. Clinical manifestations and organ involvement.
Clinical manifestation Yes (%) No (%)
Bacteraemia 145 (74) 52 (26)
Abscess in any location a 89 (53) 77 (47)
Pneumonia b 101 (61) 65 (39)
Skin and soft tissue involvement c 28 (17) 136 (83)
Liver or spleen involvement c 28 (18) 127 (82)
Genitourinary involvement c 38 (24) 121 (76)
Musculoskeletal involvement c 26 (16) 133 (84)
Central nervous system involvement c 6 (4) 148 (96)
a Includes lung abscesses and empyema.
b Determined by review of chest X-ray.
c Determined on review of medical records, microbiological specimens and medical imaging. Note: patients
could meet criteria for inclusion in multiple categories.
doi:10.1371/journal.pntd.0005411.t004
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Almost 80% of clinical presentations occurred during the region’s wet season, a very similar
figure to that seen the hyper-endemic Top End of the Northern Territory [4, 15] and northeast
Thailand [16]. This association with rainfall reflects the increased B. pseudomallei load in the
top soil and surface water which is thought to result from the rising water table [17], improved
bacterial survival in soil with a high moisture content [18, 19], and more vegetation for coloni-
sation [19]. However, while presentations are linked strongly to rainfall, the importance of
other patient and environmental factors is emphasised by the fact there were only three cases
seen in patients from the Cassowary Coast Region during the entire study period. This is nota-
ble because the region has the highest mean rainfall in Australia, a population of over 30,000
and Australia’s highest incidence of leptospirosis, a disease that is also acquired percutaneously
[1, 20–22].
Two of the largest cyclones ever recorded in the region occurred during the study period
(Cyclone Larry (March 2006) and Cyclone Yasi (February 2011)). While adverse weather
events have been linked to an increase in melioidosis presentations [23], in the three months
following Cyclone Larry there were only four cases and after Cyclone Yasi only three; two of
these seven cases occurred in the Torres Strait, over 800km to the North. The eye of both
cyclones passed through the Cassowary Coast region, but on neither occasion was there a case
locally.
The incidence rates reported in the Torres Strait are amongst the highest ever described in
Australia [24]. This presumably reflects a combination of an increased prevalence of the
comorbidities linked to melioidosis in Torres Strait residents—83% of whom identify as
ATSI–and increased recreational and occupational exposure. Whether there are other local
Fig 5. Age at presentation and case-fatality rate.
doi:10.1371/journal.pntd.0005411.g005
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factors in the Torres Strait which are contributing to this relatively high incidence (soil charac-
teristics, local precipitation and land surface temperature variability and vegetation differ-
ences) is a subject of ongoing study.
Almost all the patients in the series had a recognised risk factor for the disease, including
diabetes mellitus, hazardous alcohol use, chronic kidney disease and chronic lung disease,
reinforcing the notion that melioidosis is predominantly an opportunistic infection in an at
risk population [4, 6, 25, 26]. Indeed, only a few patients had no risk factor for the disease; of
the 14 patients without any documented risk factors, four were children and three had clear
inoculation events. Our data concords with an earlier Australian study that has shown male
sex to be an independent risk factor for melioidosis, presumably due to increased exposure
risk [27]. The rate of bacteraemia (74%) seen in this study is higher than that seen in the pro-
spective survey from the Northern Territory (55%) [28]. This may be related to our study pop-
ulation having a higher rate of risk factors for bacteraemia (ATSI ethnicity, older age, diabetes,
alcohol misuse and kidney disease) than the Northern Territory cohort.
Unfortunately, 23 patients had incomplete risk factor data available; this was usually the
result of destroyed charts. Among these 23 patients, there were 10 deaths, which represented
over one third of the deaths in the cohort. This missing data limited our ability to perform
meaningful statistical analysis of the association between individual comorbidities and mortal-
ity. No comorbidity, other than chronic kidney disease, was associated with increased risk of
death.
Across the entire region, the incidence of melioidosis was over seven times higher in the
ATSI population than in the non-ATSI population. This is almost certainly at least partly
Table 5. Cases of disease recurrence with potential explanations.
Age/
Sex
Adherent to Darwin Recommended
duration of intravenous therapy [10]
(Number of weeks received)
Recrudescence or
relapse
Primary site of
disease
Abscess
site
Adequate
source
control
Documented
adherence to oral
eradication therapy
Died
18M No (0.5) Recrudescence Parotitis Parotid Yes No No
29M No (1) Relapse Skin Skin/soft
tissue
Yes No No
31M Yes (4) Recrudescence Disseminated Skin/liver/
pancreas
No a No f No
43M Yes (4) Recrudescence Bacteraemia Prostate No b No f No
61M Yes (6) Recrudescence Pneumonia Prostate No c Yes f No
38M Yes (6) Recrudescence Pneumonia &
bacteraemia
Liver No d No No
50F Yes (4) Recrudescence Pneumonia Nil Not required Unknown e, f Yes
26M Yes (2) Recrudescence Pneumonia Nil Not required No No
31F Yes (7) Relapse Disseminated Septic
arthritis
Yes No No
47F Yes (6) Relapse Pneumonia Nil Not required No Yes
64F Yes (2) Recrudescence Skin Skin/soft
tissue
No g No No
a Managed conservatively.
b Patient declined surgical intervention.
c Initial imaging revealed unilateral swelling but unamenable to drainage.
d Unamenable to radiologically guided drainage.
e Missed 72 hours of intravenous therapy due to cyclone (although course extended).
f Recrudesced within one month of ceasing intensive phase therapy.
g Surgery deferred in favour of antibiotics.
doi:10.1371/journal.pntd.0005411.t005
Melioidosis in Far North Queensland
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005411 March 6, 2017 10 / 15
explained by the increased prevalence of the comorbidities associated with melioidosis in the
ATSI population. In Far North Queensland, the prevalence of diabetes mellitus is three-fold
higher, alcohol abuse two-fold higher and chronic kidney disease six-fold higher in the ATSI
population than the non-ATSI population [29–31]. It has also been suggested that the higher
rates of melioidosis in the ATSI population may relate to increased exposure [4]. Not only did
the ATSI population bear a greater burden of disease, they also had disease at a younger age
and a higher case-fatality rate. This reflects the stubbornly persistent “gap” in health outcomes
between ATSI and non-ATSI populations in Australia [32], strongly linked to the socioeco-
nomic determinants of disease and reduced access to health care. In this series, the ATSI
patients were more likely to have multiple risk factors for the disease that not only predisposed
them to developing melioidosis but also—through decreasing physiological reserve—presum-
ably contributed to their worse outcomes.
The low incidence in children echoes findings from the Northern Territory [33]. These
Australian data are notable, as the disease is seen more frequently in children in some parts of
South East Asia [34, 35], which may reflect the fact that unchlorinated domestic water supplies
are contaminated with B. pseudomallei in these locations [6, 33, 36]. The reduced likelihood of
exposure to B. pseudomallei in drinking water is also reflected in the finding that only two
patients had parotid abscesses. Although the literature suggests a low case-fatality rate in chil-
dren [33, 34], all three children in the series under the age of ten (ages 0, 5 and 6 years old),
died from the disease within 48 hours of presentation. None of the children had identifiable
risk factors, although one child died within the neonatal period. Elderly patients also had a
higher mortality, although this presumably reflects the decreased physiological reserve of older
individuals.
Recognising that adherence to the extended oral eradication phase of treatment is fre-
quently suboptimal, Darwin investigators have recently proposed a new treatment approach.
This is based on the observation that progressive lengthening of duration of intensive intrave-
nous therapy at their institution has been associated with a reduction in relapse rates, even
though these patients still have a high rate of non-adherence to the eradication phase [10]. If
these findings were reproducible, this would influence International treatment guidelines and
support a longer course of intensive intravenous therapy, which might potentially allow the
oral eradication phase of therapy to be abbreviated or avoided altogether. Our study provided
an opportunity to assess the Darwin approach but we were unable to demonstrate that a longer
duration of intensive intravenous therapy in our patients reduced disease recurrence. Disease
recurrence was no lower in the patients who had completed a period of intensive intravenous
therapy consistent with the Darwin guidelines. Indeed, the only deaths in patients with recur-
rent disease occurred in patients with prolonged intravenous therapy (although this is almost
certainly the result of unfavourable clinical characteristics—disease burden and patient comor-
bidities—rather than a complication of the prolonged therapy). Instead, disease recurrence
was explained more commonly by inadequate source control and an inadequate duration of
oral eradication therapy secondary to non-adherence. The first point is not surprising as
source control is fundamental to the management of infection [37] while an inadequate dura-
tion of oral therapy is consistent with findings from a Thai series where duration of oral ther-
apy was identified as one of the strongest predictors of relapse [9]. Patients who are not able to
complete an adequate duration of prescribed oral eradication therapy might also be anticipated
to be a population less inclined to engage with medical services. This would preclude optimal
management of the comorbidities that predisposed them to the disease, potentially facilitating
perpetuation and reactivation of this opportunistic pathogen. In the absence of molecular typ-
ing, our inability to differentiate early reinfection from relapse will influence our treatment
outcome comparisons. However, reinfection is relatively uncommon within the 2-year
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window of our case definition for relapse [13]. While our findings in a retrospective cohort do
not preclude the possibility that an extended period of intensive intravenous therapy will have
salutary effects on patient outcomes, they underline the fact that frequently the more prosaic,
but fundamental, aspects of disease management should not be overlooked. A prospective,
randomised controlled trial may help better define the optimum durations of intravenous
therapy for melioidosis.
The case-fatality rate fell impressively during the study period, echoing findings from Dar-
win where a similar improvement was attributed predominantly to improvements in the ICU
management of the sepsis [38]. Indeed, this is a trend that has been seen Australia-wide in all
bacterial sepsis, not just in melioidosis [39]. However, unlike Darwin, granulocyte colony-
stimulating factor is not routinely used in the management of patients critically ill with melioi-
dosis in Far North Queensland [38]. The fact that a third of all deaths occurred within the first
48 hours of presentation emphasises the importance of prompt ICU care. Interestingly, the
overall case fatality rate was no higher in the patients coming from remote locations than those
patients living within 30 minutes of Cairns hospital. This likely reflects the ability of clinicians
working in remote parts of Far North Queensland to recognise critically ill patients, and the
efficiency of retrieval services in transporting these patients long distances to receive tertiary
level support. Other factors that may have contributed to the improvement in mortality over
the period of the study include improvements in imaging which may have identified previ-
ously unrecognised foci. Improved access to digital education resources over the study period
also permitted the promulgation of guidelines for the recognition and management of the dis-
ease, which may also have contributed to superior outcomes.
The relatively high disease burden in remote Cape York and the Torres Strait communities
may help guide empiric antibiotic therapy in patients presenting with sepsis in these commu-
nities. Clearly, meropenem should be in the essential medicines list for the Far North Queens-
land retrieval service given the recognition that delays in the administration of appropriate
antibiotic therapy in septic patients is linked to increased mortality [40]. In the appropriate
clinical situation empiric therapy that covers the possibility of melioidosis may be lifesaving,
however, it should be noted that even in endemic areas such as Far North Queensland, other
pathogens are a more common cause of community-acquired sepsis. For example, over the
last five years of the study period, there were 76 cases of B. pseudomallei bacteraemia, but dur-
ing the same time period Cairns Hospital managed 661 cases of community-acquired Escheri-
chia coli bacteraemia and 389 cases of community-acquired Staphylococcus aureus
bacteraemia.
Our study has limitations. Its retrospective nature resulted in incomplete data collection,
limiting multivariate statistical analysis in particular. Comparisons with results from Darwin
are particularly fraught given the prospective nature of data collection in that centre, although
the independent dataset permits external validation–at least to some degree–of the recommen-
dations of that high-volume unit.
In conclusion melioidosis in Far North Queensland is an opportunistic infection of patients
with specific comorbidities that presents predominantly in the wet season. Differences in inci-
dence across the region almost certainly reflect to some degree differences in exposure and
risk factor prevalence, however as yet undefined environmental factors appear to make a sig-
nificant contribution. The ATSI population who have a higher prevalence of the risk factors
for melioidosis, bear the greatest burden of the disease. Disease recurrence is higher in patients
with inadequate source control and suboptimal adherence, factors which are not necessarily
mitigated by extending the duration of intravenous therapy. Survival is improving as is the
case with other aetiologies of bacterial sepsis, however as the majority of deaths occur early in
the patient’s hospitalisation prompt consideration of the diagnosis and administration of
Melioidosis in Far North Queensland
PLOS Neglected Tropical Diseases | DOI:10.1371/journal.pntd.0005411 March 6, 2017 12 / 15
appropriate antibiotic therapy is critical to reduce case-fatality rates further. Prospective multi-
centre studies will help determine optimal disease management strategies.
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